Determination of the Pattern of Antibiotic Resistance and Investigation of Extended-Spectrum Beta-Lactamase Production of Enterobacteriaceae Isolates of Clinical Specimens

Mojde Safari; Hamid  Abtahi; Mana Shojapoor; Majid Akbari; Ahamadali Poorbabayi

Zahedan Journal of Research in Medical Sciences

The Official Journal of Zahedan University of Medical Sciences

Current Issue All Issues In Press Articles Accepted Manuscripts Search

Journal Information Boards and Committees Indexing and Listing Sources Journal Metrics Open Peer Review (OPR)Publication Ethics and Malpractice Statement Contact Us Support Reviewer and AE Registration Form

APC

Authors Guide Submit Manuscript

Determination of the Pattern of Antibiotic Resistance and Investigation of Extended-Spectrum Beta-Lactamase Production of Enterobacteriaceae Isolates of Clinical Specimens

Author(s):

Mojde Safari¹,

Hamid Abtahi^2,*,

Mana Shojapoor²,

Majid Akbari²,

Ahamadali Poorbabayi¹

1Department of Microbiology, Faculty of Fundamental Sciences, Qom Azad University

2Department of Microbiology, Molecular and Medicine Research Center, Arak University of Medical Sciences

Zahedan Journal of Research in Medical Sciences:Vol. 14, issue 8; e93266

Published online:Jan 20, 2012

Article type:Research Article

Received:Sep 27, 2011

Accepted:Oct 19, 2011

How to Cite:Mojde SafariHamid AbtahiMana ShojapoorMajid AkbariAhamadali PoorbabayiDetermination of the Pattern of Antibiotic Resistance and Investigation of Extended-Spectrum Beta-Lactamase Production of Enterobacteriaceae Isolates of Clinical Specimens.Zahedan J Res Med Sci.14(8):e93266.

Abstract

Background : Extended-spectrum beta-lactamase (ESBLs) producing bacteria are issued as a serious problem considering their ability to hydrolyze most of beta-lactam antibiotics. The outbreak of infections derived by ESBL-producing enterobacteriaceae is increasing throughout the world. Therefore, this study aims to determine a pattern of antibiotic resistance and investigate the extended-spectrum beta-lactamases production of enterobacteriaceae isolates separated from clinical specimens.
Materials and Methods : In this study, 170 various strains of enterobacteriaceae isolated from clinical specimens in teaching hospitals of Arak cultured and identified applying standard methods during one year (2010-2011). The antibiotic resistance of isolates was investigated through disk Agar diffusion according to CLSI criteria. The resistant isolates against ceftazidime and cefotaxime antibiotics were studied through the combined disk test for the final confirmation of ESBL-production. The minimum inhibitory concentration was determined through micro broth dilution.
Results : In this study, the resistance rate of various strains of enterobacteriaceae against amoxiclav, cefotaxime, ceftriaxone, ceftazidime, cefoxitin, cefotetan, meropenem and imipenem were respectively, 91.1%, 70%, 68.8%, 62.9%, 28.2%, 11.1%, 11.1% and 1.7%. Among 125 resistant enterobacteriaceae isolates against ceftazidime or cefotaxime, 108 isolates (86.4%) had ESBL-positive phenotype and 17 isolates (13.6%) had ESBL-negative phenotype. The MICs of the resistant isolates were indicated within a range of 16 to 512 µg/ml for ceftazidime and 64 to 512 µg/ml for cefotaxime.
Conclusion : According to the results of this study, imipenem is the most effective antimicrobial antibiotic. On the other hand, the present study indicates that the bacteria within the family of ESBL producing enterobacteriaceae are highly prevalent among the patients. The increase in rate of such cases is often resulted by irrational antibiotic prescription. Application of new antimicrobials, limitation of the use of antimicrobial factors and increasing the utilization of infection control tools are all required in order to solve this problem.

Keywords

Antibiotic resistance

Extended-spectrum beta-lactamases (ESBLs)

minimum inhibitory

concentration

Fulltext

The full text of this article is available on the PDF file.

References

1.
The References of this article are available on the PDF file.

comments